Mumbai, 2026

The Scientific Capital Table

40 people. One table. One question: 
How do we create a capital market for science?

Request an Invitation

Read the Proposition

Date

5 October 2026

Venue

Nishith Desai Associates, BKC

Seats

40, personally composed

Access

By invitation only

THE PREMISE

Science is producing assets faster than capital markets can finance them.

India is creating world-class scientific IP, datasets and development programs. AI now makes it possible to value scientific progress in real time. The question is no longer whether — buthow— to create a capital market for these assets.

"The problem is not a shortage of innovation; it is the absence of a mechanism to finance intangible scientific assets independently of the corporate wrapper."

$195.3B

India Bioeconomy 2030 Target

-48%

Private Cap Contraction (YoY)

THE STRUCTURAL FRICTION

Why Traditional VC Fails Deep Science Assets

01 / VOLATILITY

Binary & Lumpy Outcomes

Clinical trial readouts and regulatory milestones create step-function returns, not smooth revenue growth curves.

02 / BENCHMARKING

Thin Actuarial History

Lack of standardized historical comparables prevents institutional risk pricing and underwriting mechanisms.

03 / HORIZON

Long Duration to Liquidity

10–15 year scientific development lifecycles directly clash with standard 7–10 year venture fund mandates.

04 / INFORMATION

Researcher-Investor Gap

High technical complexity creates acute information asymmetry between scientific creators and capital allocators.

THE CAMPAIGN CONTINUUM

A Global Journey Towards a New Asset Class

Click any milestone to explore its strategic brief, participant focus, and structural outcomes.

STAGE 01 • DELHI

COMPLETED

The Proposition

Framing the legal & public market infrastructure for scientific assets.

Explore Brief

STAGE 02 • MUMBAI

OCT 5 • LIVE

The Market Table

40 decision-makers assembled at NDA BKC & Indian Accent.

Request Seat at Table

STAGE 03 • SINGAPORE

NEXT UP

The Network

Connecting Indian science assets to global RWA digital asset rails at TOKEN2049.

View Syndicate Brief

STAGE 04 • EXECUTION

OUTCOME

First Transactions

Issuing Scientific Asset Receipts (SARs) backed by live clinical datasets.

Read Pilot Mode

THE CONSTITUENCY

40 Seats. Five Pillars.

Curated to assemble the essential decision-makers needed to structure a scientific capital market.

Family Offices & Sovereign Allocators

Strategic Pharma & Biotech CEOs

Market Intermediaries & Advisory Leaders

Policy & Regulatory Voices

Global Digital Asset & RWA Protocols

CONVENING AGENDA

OCTOBER 5, 2026

16:00 – 18:30

Working Session

Nishith Desai Associates, BKC. Closed-door legal & market architecture design.

19:00 – 19:45

Private Reception

Indian Accent, Jio World Centre. Executive introductions & networking.

20:00 – 22:30

Founding Dinner

Multi-course culinary experience paired with strategic keynotes.

BY INVITATION ONLY

Request a Seat at The Scientific Capital Table

Participation is strictly limited to 40 primary decision-makers across Sovereign Funds, Family Offices, Biopharma CEOs, Market Intermediaries, and Policy Leaders.